Annual Drug Patent Expirations for EVZIO+%28AUTOINJECTOR%29
Evzio (autoinjector) is a drug marketed by Kaleo Inc and is included in one NDA. It is available from two suppliers. There are thirty patents protecting this drug.
Drug patent litigation for EVZIO (AUTOINJECTOR).
This drug has one hundred and thirty-eight patent family members in fifteen countries.
The generic ingredient in EVZIO (AUTOINJECTOR) is naloxone hydrochloride. Two suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
